NM_001365536.1:c.1469G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001365536.1(SCN9A):​c.1469G>A​(p.Ser490Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,613,832 control chromosomes in the GnomAD database, including 758 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S490T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.041 ( 389 hom., cov: 31)
Exomes 𝑓: 0.0078 ( 369 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 0.386

Publications

18 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016465783).
BP6
Variant 2-166286469-C-T is Benign according to our data. Variant chr2-166286469-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.129 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.1469G>A p.Ser490Asn missense_variant Exon 11 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.1469G>A p.Ser490Asn missense_variant Exon 11 of 27 NM_001365536.1 ENSP00000495601.1 Q15858-1
SCN9AENST00000303354.11 linkc.1469G>A p.Ser490Asn missense_variant Exon 11 of 27 5 ENSP00000304748.7 Q15858-1
SCN9AENST00000409672.5 linkc.1469G>A p.Ser490Asn missense_variant Exon 11 of 27 5 ENSP00000386306.1 Q15858-3
SCN9AENST00000645907.1 linkc.1469G>A p.Ser490Asn missense_variant Exon 11 of 27 ENSP00000495983.1 Q15858-4
SCN9AENST00000454569.6 linkc.1469G>A p.Ser490Asn missense_variant Exon 11 of 15 1 ENSP00000413212.2 A0A0C4DG82

Frequencies

GnomAD3 genomes
AF:
0.0412
AC:
6264
AN:
152116
Hom.:
389
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.132
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0200
Gnomad ASJ
AF:
0.0282
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0160
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.00353
Gnomad OTH
AF:
0.0349
GnomAD2 exomes
AF:
0.0152
AC:
3780
AN:
249102
AF XY:
0.0140
show subpopulations
Gnomad AFR exome
AF:
0.136
Gnomad AMR exome
AF:
0.00849
Gnomad ASJ exome
AF:
0.0358
Gnomad EAS exome
AF:
0.0000557
Gnomad FIN exome
AF:
0.0000928
Gnomad NFE exome
AF:
0.00368
Gnomad OTH exome
AF:
0.0137
GnomAD4 exome
AF:
0.00775
AC:
11334
AN:
1461598
Hom.:
369
Cov.:
31
AF XY:
0.00789
AC XY:
5734
AN XY:
727074
show subpopulations
African (AFR)
AF:
0.136
AC:
4536
AN:
33464
American (AMR)
AF:
0.0102
AC:
456
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0369
AC:
965
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.0173
AC:
1492
AN:
86224
European-Finnish (FIN)
AF:
0.000169
AC:
9
AN:
53398
Middle Eastern (MID)
AF:
0.0298
AC:
172
AN:
5768
European-Non Finnish (NFE)
AF:
0.00245
AC:
2728
AN:
1111824
Other (OTH)
AF:
0.0162
AC:
975
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
535
1070
1606
2141
2676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0413
AC:
6287
AN:
152234
Hom.:
389
Cov.:
31
AF XY:
0.0398
AC XY:
2964
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.132
AC:
5478
AN:
41526
American (AMR)
AF:
0.0201
AC:
307
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0282
AC:
98
AN:
3472
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5170
South Asian (SAS)
AF:
0.0164
AC:
79
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00353
AC:
240
AN:
68018
Other (OTH)
AF:
0.0346
AC:
73
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
278
556
833
1111
1389
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0180
Hom.:
266
Bravo
AF:
0.0455
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.125
AC:
464
ESP6500EA
AF:
0.00538
AC:
44
ExAC
AF:
0.0169
AC:
2039
Asia WGS
AF:
0.0130
AC:
46
AN:
3476
EpiCase
AF:
0.00540
EpiControl
AF:
0.00682

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 22, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19763161, 27884173) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary erythromelalgia Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Channelopathy-associated congenital insensitivity to pain, autosomal recessive Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Small fiber neuropathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Paroxysmal extreme pain disorder Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Benign
0.23
.;T;.;.;T;.;.
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.042
FATHMM_MKL
Benign
0.65
D
LIST_S2
Benign
0.71
T;.;T;T;T;T;T
MetaRNN
Benign
0.0016
T;T;T;T;T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
0.69
N;N;N;.;N;N;.
PhyloP100
0.39
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.48
N;N;.;.;.;N;.
REVEL
Benign
0.23
Sift
Benign
0.24
T;D;.;.;.;T;.
Sift4G
Benign
0.41
T;T;.;.;.;T;.
Polyphen
0.0
.;B;.;.;B;.;.
Vest4
0.060
MPC
0.11
ClinPred
0.0048
T
GERP RS
4.0
Varity_R
0.053
gMVP
0.27
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58022607; hg19: chr2-167142979; COSMIC: COSV104409075; API